Numbers of compounds undergoing clinical evaluation and their source derivation
a reduced number
There were 62 antibacterial clinical candidates under clinical investigation (Figs. While there was a similar number of compounds in the different development phases in 2011, 2013 and 2015 analyses (except for a reduced number in phase-III trials in 2011 (6) compared to 2013 (16) and 2015 (15)), the number in phase-I trials increased to 22 in 2019 [